ge sold its biopharma business for $21b in all cash to danaher .  ge will use the proceeds to pay down a portion of its  $100b debt pile amid an ongoing turnaround effort  .  ge has lost about two thirds of its market value over the last  2 years and was removed from the dow jones index in 2018 . 
